CytoDyn's (CYDY) most recent (4/17/20) Wall Street Live, "Next Superstock" promo, was worth the time invested for those who are trying to make sense of a CytoDyn investment. It was a new format with CytoDyn's hard-working CEO Nader Pourhassan [NP] moderating a series of questions for CytoDyn's two medical gurus, Drs. Bruce Patterson and Jacob Lalezari. Here are my takeaways.
The FDA has allowed CytoDyn to evaluate leronlimab in the treatment of COVID-19 in two clinical trials and as an EIND
In CytoDyn's recent leronlimab overview promo, it presented the